These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 27786018)

  • 1. Competitive Inhibitor Binding Assay (IBA) of Captopril and Other Inhibitors of Angiotensin Converting Enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):13-16. PubMed ID: 27786018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol Suppl; 1984; 79():13-6. PubMed ID: 6089313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibitor binding assay (CIBA) of captopril and other ACE inhibitors.
    Grönhagen-Riska C; Tikkanen I; Fyhrquist F
    Clin Chim Acta; 1987 Jan; 162(1):53-60. PubMed ID: 3026689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibitor binding assay (CIBA) of ACE inhibitors.
    Grönhagen-Riska C; Tikkanen I; Fyhrquist F
    Acta Med Scand Suppl; 1986; 714():43-7. PubMed ID: 3033999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor binding assay for angiotensin-converting enzyme.
    Fyhrquist F; Tikkanen I; Grönhagen-Riska C; Hortling L; Hichens M
    Clin Chem; 1984 May; 30(5):696-700. PubMed ID: 6325041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor binding assay of rat serum angiotensin converting enzyme.
    Tikkanen I; Fyhrquist F; Forslund T
    Clin Sci (Lond); 1984 Aug; 67(2):237-41. PubMed ID: 6086211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.
    Lieberman J; Zakria F
    Sarcoidosis; 1989 Sep; 6(2):118-23. PubMed ID: 2557660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of angiotensin converting enzyme.
    Fyhrquist F; Grönhagen-Riska C; Hortling L; Forslund T; Tikkanen I
    J Hypertens Suppl; 1983 Oct; 1(1):25-30. PubMed ID: 6100606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
    Bünning P
    Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
    Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
    J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay.
    Jackson B; Cubela R; Johnston CI
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):699-704. PubMed ID: 2442537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits.
    Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):37-42. PubMed ID: 11881065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
    Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
    Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.